![GORE EXCLUDER AAA Endoprosthesis](/sites/default/files/styles/max_750x750/public/2018-11/EXCBLD01012-Hero-2000x1000px_2.jpg.webp?itok=puxeFAOH)
![urgent product safety information](/sites/default/files/styles/max_100_x_100_web/public/2020-01/product-satefy-bug_3.png.webp?itok=IUb4MiPB)
GORE® EXCLUDER® AAA Endoprosthesis
With more than 20 years of experience, the trusted performance of the GORE® EXCLUDER® Device is paired with the intuitive GORE® C3® Delivery System to provide optimal infrarenal seal and reliable results, even in more challenging anatomies.
![results from the Global Registry for Endovascular Aortic Treatment (GREAT)](/sites/default/files/styles/max_450x450/public/2019-11/AY1654-EN1-EXC-WEB-Graphics-1-FNL_0.jpg.webp?itok=UH03R4Ib)
Long-term durability: 96.0% freedom from device-related reintervention and 0.7% limb occlusion through five-year follow-up.*
![350000 patients treated](/sites/default/files/styles/max_450x450/public/2019-11/AY1654-EN1-EXC-WEB-Graphics-2-FNL_0.jpg.webp?itok=p4VCvPla)
Twenty years of evidence: Worldwide experience with time-tested results
* GREAT. n = 3,274. To calculate the overall event rates from procedure through end of study period, all subjects who could have had events, regardless of length of follow-up, were included. For outcome data, GREAT only collects site reported serious adverse events. Therefore, all reported endoleaks are defined as serious and require reintervention.
† One peri-procedural migration reported. Zero migrations reported during follow-up through 5 years.